Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Albers

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Physical Review Letters|June 4, 2011
Coherent heavy quasiparticles in a CePt5 surface alloyM Klein, A Nuber, H Schwab, et al.
Allergy and Asthma Proceedings|July 3, 2019
Association of depressive symptoms with health status and markers of uncontrolled severe asthmaSandhya Khurana, Jeffrey M Lyness, Stephen Mallett, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2025
Screening for cognitive impairment in routine clinical oncology practice: a pilot study using patient-reported outcome measures and online cognitive testing in melanoma and breast cancer patientsE A C Albers, K M de Ligt, I M C van der Ploeg, et al.
The New England Journal of Medicine|May 15, 2022
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for AsthmaAlberto Papi, Bradley E Chipps, Richard Beasley, et al.
Physical Review Letters|October 27, 2011
Understanding the complex phase diagram of uranium: the role of electron-phonon couplingS Raymond, J Bouchet, G H Lander, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2025
Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitorsE A C Albers, M J Luijendijk, M Egeler, et al.
Respiratory Research|May 11, 2021
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristicsMark C Liu, Bradley Chipps, Xavier Munoz, et al.
Clinical Therapeutics|August 27, 2019
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX StudySandhya Khurana, Guy G Brusselle, Elisabeth H Bel, et al.
Journal of Patient-Reported Outcomes|March 3, 2022
Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracyElaine A C Albers, Itske Fraterman, Iris Walraven, et al.
The Journal of Allergy and Clinical Immunology|October 26, 2018
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthmaSumita Khatri, Wendy Moore, Peter G Gibson, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Physical Review Letters|June 4, 2011
Coherent heavy quasiparticles in a CePt5 surface alloyM Klein, A Nuber, H Schwab, et al.
Allergy and Asthma Proceedings|July 3, 2019
Association of depressive symptoms with health status and markers of uncontrolled severe asthmaSandhya Khurana, Jeffrey M Lyness, Stephen Mallett, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2025
Screening for cognitive impairment in routine clinical oncology practice: a pilot study using patient-reported outcome measures and online cognitive testing in melanoma and breast cancer patientsE A C Albers, K M de Ligt, I M C van der Ploeg, et al.
The New England Journal of Medicine|May 15, 2022
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for AsthmaAlberto Papi, Bradley E Chipps, Richard Beasley, et al.
Physical Review Letters|October 27, 2011
Understanding the complex phase diagram of uranium: the role of electron-phonon couplingS Raymond, J Bouchet, G H Lander, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2025
Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitorsE A C Albers, M J Luijendijk, M Egeler, et al.
Respiratory Research|May 11, 2021
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristicsMark C Liu, Bradley Chipps, Xavier Munoz, et al.
Clinical Therapeutics|August 27, 2019
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX StudySandhya Khurana, Guy G Brusselle, Elisabeth H Bel, et al.
Journal of Patient-Reported Outcomes|March 3, 2022
Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracyElaine A C Albers, Itske Fraterman, Iris Walraven, et al.
The Journal of Allergy and Clinical Immunology|October 26, 2018
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthmaSumita Khatri, Wendy Moore, Peter G Gibson, et al.
Pageof 13